John Markels
Director/Board Member at SANGAMO THERAPEUTICS, INC.
Net worth: 21 764 $ as of 30/03/2024
Profile
John H.
Markels is an Independent Director at Sangamo Therapeutics, Inc. He is also a Director at Arcturus Therapeutics, Inc., Arcturus Therapeutics Ltd., and Arcturus Therapeutics Holdings, Inc. Previously, he served as the President-Global Vaccines at Merck & Co., Inc. Dr. Markels holds a doctorate degree from the University of California, Berkeley and an undergraduate degree from the University of Delaware.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 07/04/2024 | 32,484 ( 0.02% ) | 21 764 $ | 30/03/2024 | |
| 14/04/2023 | 0 ( -.--% ) | - $ | 30/03/2024 |
John Markels active positions
| Companies | Position | Start |
|---|---|---|
| SANGAMO THERAPEUTICS, INC. | Director/Board Member | 10/02/2020 |
| ARCTURUS THERAPEUTICS HOLDINGS INC. | Director/Board Member | 07/12/2022 |
Arcturus Therapeutics, Inc.
 Arcturus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Arcturus Therapeutics, Inc. engages in the development of technology and therapeutics for rare diseases. It specializes in the application of application of ribonucleic acid technologies for the treatment of disease. The company was founded by Joseph E. Payne and Padmanabh Chivukula in 2013 and is headquartered in San Diego, CA. | Director/Board Member | - |
Arcturus Therapeutics Ltd.
 Arcturus Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Arcturus Therapeutics Ltd. engages in the provision of RNA medicines, which focuses on liver and respiratory diseases. Its RNA medicines include mRNA; siRNA, miRNA, and ASO;, CRISPR, TALEN, and meganucleases; and Replicon RNA and DNA. The company was founded by Joseph Payne in March 2013 and is headquartered in San Diego, CA. | Director/Board Member | - |
Former positions of John Markels
| Companies | Position | End |
|---|---|---|
| MERCK & CO., INC. | Corporate Officer/Principal | 28/02/2022 |
Training of John Markels
| University of California, Berkeley | Doctorate Degree |
| University of Delaware | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| MERCK & CO., INC. | Health Technology |
| SANGAMO THERAPEUTICS, INC. | Health Technology |
| ARCTURUS THERAPEUTICS HOLDINGS INC. | Health Technology |
| Private companies | 2 |
|---|---|
Arcturus Therapeutics, Inc.
Arcturus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Arcturus Therapeutics, Inc. engages in the development of technology and therapeutics for rare diseases. It specializes in the application of application of ribonucleic acid technologies for the treatment of disease. The company was founded by Joseph E. Payne and Padmanabh Chivukula in 2013 and is headquartered in San Diego, CA. | Health Technology |
Arcturus Therapeutics Ltd.
Arcturus Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Arcturus Therapeutics Ltd. engages in the provision of RNA medicines, which focuses on liver and respiratory diseases. Its RNA medicines include mRNA; siRNA, miRNA, and ASO;, CRISPR, TALEN, and meganucleases; and Replicon RNA and DNA. The company was founded by Joseph Payne in March 2013 and is headquartered in San Diego, CA. | Health Technology |
- Stock Market
- Insiders
- John Markels
